CI

CI

USD

The Cigna Group Common Stock

$264.660+6.960 (2.701%)

即時價格

Healthcare
Healthcare Plans
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$257.700

最高

$264.800

最低

$256.000

交易量

3.20M

公司基本面

市值

70.7B

行業

Healthcare Plans

國家

United States

交易統計

平均交易量

1.74M

交易所

NYQ

貨幣

USD

52週範圍

最低 $239.51當前 $264.660最高 $350

AI分析報告

最後更新: 2025年11月3日
由AI生成數據來源: Yahoo Finance, Bloomberg, SEC

Cigna (CI) Stock Analysis: Finding Opportunity in Recent Turmoil

What Happened to Cigna's Stock?

Cigna took a serious hit recently. On October 30th, shares plunged 18% to $247.10 on massive volume - nearly 5.5 times their average trading activity. The selling continued the next day, dropping the stock to $244.41. This puts CI dangerously close to its 52-week low of $240.67.

What's puzzling is this crash happened despite generally positive news. The company beat Q3 earnings estimates, Goldman Sachs just initiated coverage with a strong Buy rating and $370 price target (that's 50% above current levels), and they announced meaningful initiatives to reduce medication costs for Americans.

Reading Between the Price Lines

Let's unpack what's really happening with Cigna's chart:

  • The Setup: Through most of August and September, CI built a solid upward trend, climbing from $260 to over $310
  • The Breakdown: After peaking near $315, the stock drifted lower through October
  • The Crash: That October 30th drop was no ordinary correction - it was a full-blown panic sell-off

Here's what stands out: the volume spike on October 30th wasn't normal distribution. When volume jumps that high during a sharp decline, it usually means big institutional players are exiting positions all at once. The good news? The selling pressure appears exhausted - the follow-through day on October 31st showed much weaker volume.

Why This Might Be Your Entry Window

Three compelling reasons suggest the worst may be over:

  1. Technical Signals Flashing Green: The stock now sits right at its support level ($244.33). When prices bounce off support with conviction, it often marks a turning point. Right now, the distance between current price and support is practically nonexistent - meaning we're at the make-or-break point.

  2. Goldman's Confidence: Their $370 price target isn't some random number. At current levels, that represents serious upside potential. What's interesting is they're not alone - 24 analysts maintain strong buy ratings.

  3. The News/Price Disconnect: Positive earnings, strategic initiatives, and dividend stability shouldn't result in an 18% single-day drop. This mismatch creates what traders call "mispricing" - a temporary gap between actual value and market price

相關新聞

Analyst Upgrades

Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market

Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.

查看更多
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Analyst Upgrades

TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333

TD Cowen analyst Charles Rhyee maintains Cigna Group with a Buy and lowers the price target from $387 to $333.

查看更多
TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333
Analyst Upgrades

Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330

Goldman Sachs analyst Scott Fidel maintains Cigna Group with a Buy and lowers the price target from $370 to $330.

查看更多
Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330
Analyst Upgrades

JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375

JP Morgan analyst Lisa Gill maintains Cigna Group with a Overweight and lowers the price target from $428 to $375.

查看更多
JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375
Analyst Upgrades

Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300

Barclays analyst Andrew Mok maintains Cigna Group with a Overweight and lowers the price target from $383 to $300.

查看更多
Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300
Reuters

Health insurer Cigna beats quarterly profit estimates on health services strength

Cigna Group beat Wall Street estimates for third-quarter profit on Thursday, driven by strength in the company's health services unit Evernorth that houses its pharmacy benefit management business.

PR Newswire

Evernorth Announces New Era of Pharmacy Benefit Services to Lower Americans' Medication Costs

Evernorth, the health services division of The Cigna Group (NYSE:CI) today announced a new rebate-free pharmacy benefit model designed to help...

AI預測Beta

AI推薦

看漲

更新於: 2025年11月5日 上午05:51

看跌中立看漲

68.6% 信心度

風險與交易

風險級別1/5
低風險
適合
保守價值
交易指南

入場點

$244.87

獲利了結

$249.29

止損

$219.96

關鍵因素

PDI 7.0 在 MDI 6.9 上方,ADX 11.9,表明看漲趨勢
交易量是平均值 (20,150) 的 12.7 倍,表明極強的買入壓力
MACD 0.2199 在信號線 0.2029 上方,表示看漲交叉

保持更新

設定價格提醒,獲取AI分析更新和即時市場新聞。